On Friday, Shares of Keryx Biopharmaceuticals (NASDAQ:KERX), included 1.59% and shut at $6.38 inside the end purchasing and offering session. The last exchanging scope of the stock ranges amongst $6.20 and $6.39. The business’ commercial center capitalization is $685.70 million with the aggregate fabulous loads of 105.96 million. Keryx Biopharmaceuticals, Inc. (KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, recently declared case study data, which showed that Auryxia® (ferric citrate) lowered and maintained serum phosphorus levels in chronic kidney disease (CKD) patients on dialysis. These data were presented in a poster presentation recently at the American Society of Nephrology’s 2016 Kidney Week taking place in Chicago.
Auryxia (ferric citrate) is presently indicated for the control of serum phosphorus levels in patients with CKD on dialysis.
“Data from this poster at ASN provide the first real-world evidence of the effect of Auryxia in treating hyperphosphatemia in people on dialysis,” said John Neylan, M.D., chief medical officer of Keryx Biopharmaceuticals. “With Auryxia available again at pharmacies, we are happy to be able to provide these data from the everyday practice setting that support Auryxia’s profile.”
Shares of Macerich Co (NYSE:MAC), subtract -0.36% and shut at $69.00 inside the last exchanging session. The rest of the purchasing and offering scope of the stock levels among $68.14 and $69.57. The association’s commercial center capitalization is $9.88 Billion with the general uncommon loads of 143.73 million. Macerich (MAC) recently declared it has been named 2016 Retail “Leader in the Light” by the National Association of Real Estate Investment Trusts (NAREIT) for a the third year in a row, an unprecedented achievement that further reinforces the company’s industry leadership in sustainability.
For the second straight year, Macerich also earned a place on CDP’s annual (2016) Climate A List, which comprises those companies identified as A grade for their actions to mitigate climate change. This ranking puts the company in the top 4% of 3,800 global companies that take part in CDP. CDP is an international not-for-profit organization formerly known as the Carbon Disclosure Project.